ClearPoint Neuro (CLPT) Short Interest Ratio & Short Volume → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free CLPT Stock Alerts $6.40 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ClearPoint Neuro Short Interest DataCurrent Short Volume1,360,000 sharesPrevious Short Volume1,230,000 sharesChange Vs. Previous Month+10.57%Dollar Volume Sold Short$7.38 millionShort Interest Ratio / Days to Cover8.7Last Record DateApril 30, 2024Outstanding Shares27,420,000 sharesPercentage of Shares Shorted4.96%Today's Trading Volume142,292 sharesAverage Trading Volume143,504 sharesToday's Volume Vs. Average99% Short Selling ClearPoint Neuro ? Sign up to receive the latest short interest report for ClearPoint Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLPT Short Interest Over TimeCLPT Days to Cover Over TimeCLPT Percentage of Float Shorted Over Time Ad Stocks NewsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarRevolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 ClearPoint Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,360,000 shares $7.38 million +10.6%N/A8.7 $5.43 4/15/20241,230,000 shares $6.90 million -3.9%N/A8.2 $5.61 3/31/20241,280,000 shares $8.70 million -8.6%N/A8.4 $6.80 3/15/20241,400,000 shares $10.01 million +0.7%N/A9 $7.15 2/29/20241,390,000 shares $8.88 million -2.8%N/A10.3 $6.39 2/15/20241,430,000 shares $10.65 million +3.6%N/A14.4 $7.45 Get the Latest News and Ratings for CLPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,380,000 shares $9.60 million +3.8%N/A13.1 $6.96 1/15/20241,330,000 shares $9.54 million No ChangeN/A12.5 $7.17 12/31/20231,330,000 shares $9.03 million -8.3%N/A13.2 $6.79 12/15/20231,450,000 shares $9.03 million -0.7%N/A15.3 $6.23 11/30/20231,460,000 shares $8.41 million +0.7%N/A15.7 $5.76 11/15/20231,450,000 shares $7.16 million +0.7%N/A15.7 $4.94 10/31/20231,440,000 shares $7.92 million No ChangeN/A15.8 $5.50 10/15/20231,440,000 shares $6.67 million +13.4%N/A14.2 $4.63 9/30/20231,270,000 shares $6.36 million -1.6%N/A12.9 $5.01 9/15/20231,290,000 shares $6.63 million +3.2%N/A12.8 $5.14 8/31/20231,250,000 shares $7.26 million +10.6%N/A7.9 $5.81 8/15/20231,130,000 shares $6.78 million No ChangeN/A6 $6.00 7/31/20231,130,000 shares $7.76 million -4.2%N/A6.3 $6.87 7/15/20231,180,000 shares $7.76 million +6.3%N/A7 $6.58 6/30/20231,110,000 shares $8.04 million +53.9%N/A6.5 $7.24 6/15/2023721,100 shares $5.02 million +0.6%N/A4.3 $6.96 5/31/2023716,700 shares $5.52 million -1.8%N/A6.8 $7.70 5/15/2023729,700 shares $6.54 million +2.5%N/A9.7 $8.96 4/30/2023712,200 shares $7.49 million -6.4%N/A10.1 $10.52 4/15/2023760,700 shares $8.04 million +1.1%N/A10.3 $10.57 3/31/2023752,600 shares $6.35 million +6.6%N/A10.6 $8.44 3/15/2023706,000 shares $5.37 million -2.1%N/A9.9 $7.61 2/28/2023720,900 shares $6.11 million +0.5%N/A10.3 $8.48 2/15/2023717,000 shares $6.52 million -2.2%N/A10.3 $9.10 1/31/2023733,200 shares $6.97 million -5.7%N/A9.6 $9.51 1/15/2023777,600 shares $8.27 million -1.3%N/A9.9 $10.63 12/30/2022788,100 shares $6.68 million -1.3%N/A9.5 $8.47 12/15/2022798,600 shares $6.57 million +1.1%N/A9.3 $8.23 11/30/2022790,100 shares $7.45 million -3.3%N/A8.6 $9.43 11/15/2022816,700 shares $8.26 million -2.0%N/A8.6 $10.11 10/31/2022833,200 shares $8.34 million -3.4%N/A7.5 $10.01 10/15/2022862,300 shares $8.31 million -6.0%N/A7.4 $9.64 9/30/2022917,100 shares $9.50 million -1.9%N/A7.7 $10.36 9/15/2022934,400 shares $11.07 million +0.5%N/A5.5 $11.85Shocking $16T Elon Musk Crypto Leak (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… CLPT Short Interest - Frequently Asked Questions What is ClearPoint Neuro's current short interest? Short interest is the volume of ClearPoint Neuro shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,360,000 shares of CLPT short. Learn More on ClearPoint Neuro's current short interest. What is a good short interest ratio for ClearPoint Neuro? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLPT shares currently have a short interest ratio of 9.0. Learn More on ClearPoint Neuro's short interest ratio. Which institutional investors are shorting ClearPoint Neuro? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ClearPoint Neuro: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ClearPoint Neuro's short interest increasing or decreasing? ClearPoint Neuro saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,360,000 shares, an increase of 10.6% from the previous total of 1,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ClearPoint Neuro's short interest compare to its competitors? Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to ClearPoint Neuro: CVRx, Inc. (9.06%), Accuray Incorporated (5.66%), Quipt Home Medical Corp. (1.61%), Alpha Tau Medical Ltd. (0.06%), Orchestra BioMed Holdings, Inc. (3.85%), TELA Bio, Inc. (4.58%), Delcath Systems, Inc. (3.34%), Profound Medical Corp. (1.27%), KORU Medical Systems, Inc. (3.46%), AVITA Medical, Inc. (6.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ClearPoint Neuro stock? Short selling CLPT is an investing strategy that aims to generate trading profit from ClearPoint Neuro as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ClearPoint Neuro? A short squeeze for ClearPoint Neuro occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLPT, which in turn drives the price of the stock up even further. How often is ClearPoint Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLPT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CVRx Short Squeeze Accuray Short Squeeze Quipt Home Medical Short Squeeze Alpha Tau Medical Short Squeeze Orchestra BioMed Short Squeeze TELA Bio Short Squeeze Delcath Systems Short Squeeze Profound Medical Short Squeeze KORU Medical Systems Short Squeeze AVITA Medical Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLPT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHow Biden has already won 2024Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsAmericans Now Need $1.46M to Retire…Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable Prosperity